DK115144B - Fremgangsmåde til fremstilling af antitussive komplekser af opiumsalkaloider. - Google Patents

Fremgangsmåde til fremstilling af antitussive komplekser af opiumsalkaloider.

Info

Publication number
DK115144B
DK115144B DK142867AA DK142867A DK115144B DK 115144 B DK115144 B DK 115144B DK 142867A A DK142867A A DK 142867AA DK 142867 A DK142867 A DK 142867A DK 115144 B DK115144 B DK 115144B
Authority
DK
Denmark
Prior art keywords
antitussive
complexes
preparation
opium alkaloids
opium
Prior art date
Application number
DK142867AA
Other languages
English (en)
Inventor
A Weber
C Mony
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Publication of DK115144B publication Critical patent/DK115144B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0042—Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK142867AA 1966-03-18 1967-03-17 Fremgangsmåde til fremstilling af antitussive komplekser af opiumsalkaloider. DK115144B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR54024A FR5227M (da) 1966-03-18 1966-03-18

Publications (1)

Publication Number Publication Date
DK115144B true DK115144B (da) 1969-09-08

Family

ID=8604122

Family Applications (1)

Application Number Title Priority Date Filing Date
DK142867AA DK115144B (da) 1966-03-18 1967-03-17 Fremgangsmåde til fremstilling af antitussive komplekser af opiumsalkaloider.

Country Status (6)

Country Link
AT (1) AT279802B (da)
BE (1) BE695604A (da)
DK (1) DK115144B (da)
FR (1) FR5227M (da)
GB (1) GB1183403A (da)
NL (1) NL6704037A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171716B1 (da) * 1982-03-12 1997-04-07 Pharmacia & Upjohn Ab Fremgangsmåde til fremstilling af et kompleks af carrageenan og emepronium, doxycyklin eller propranolol
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
AU565487B2 (en) * 1983-09-16 1987-09-17 Fisons Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4694010A (en) * 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method
US4898860A (en) * 1985-08-16 1990-02-06 New York University Anticonvulsant composition and method
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
ATE131042T1 (de) * 1990-04-25 1995-12-15 Hoechst Ag Pharmakologische zubereitung, enthaltend polyelektrolytkomplexe in mikropartikulärer form und mindestens einen wirkstoff.
IT1297461B1 (it) 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
FR2906687A1 (fr) * 2006-10-10 2008-04-11 Pierre Calleja Substrat pour la conservation et la distribution d'ingredients actifs pour animaux aquatiques

Also Published As

Publication number Publication date
NL6704037A (da) 1967-09-19
AT279802B (de) 1970-03-25
FR5227M (da) 1967-08-14
BE695604A (da) 1967-09-18
GB1183403A (en) 1970-03-04

Similar Documents

Publication Publication Date Title
DK123598B (da) Analogifremgangsmåde til fremstilling af tetrahydroisoquinoliner.
DK115144B (da) Fremgangsmåde til fremstilling af antitussive komplekser af opiumsalkaloider.
DK123482B (da) Analogifremgangsmåde til fremstilling af alkaloider.
DK117706B (da) Fremgangsmåde til fremstilling af pyrrolinderivater.
DK114697B (da) Fremgangsmåde til fremstilling af 25-desacetylderivater af rifamyciner.
DK117954B (da) Fremgangsmåde til fremstilling af 3-amino-2-cyanoacrylamid.
DK124886B (da) Fremgangsnmåde til fremstilling af 1-hydroxy-benzimidazol-N-oxider.
DK136982B (da) Fremgangsmåde til fremstilling af quinolinderivater.
DK115551B (da) Fremgangsmåde til fremstilling af 6-aminouracil-5-carbonamid-N-sulfonamider.
DK120344B (da) Fremgangsmåde til fremstilling af 5-benzyl-pyrimidiner.
DK114063B (da) Fremgangsmåde til fremstilling af 1-methyl-2-isopropyl-5-nitro-imidazol.
DK122761B (da) Analogifremgangsmåde til fremstilling af arylsulfonylurinstofderivater.
DK120132B (da) Analogifremgangsmåde til fremstilling af quinolinderivater.
DK117704B (da) Analogifremgangsmåde til fremstilling af tetrahydroisoquinolinderivater.
DK117703B (da) Analogifremgangsmåde til fremstilling af anticoccidielt aktive quinolinderivater.
DK114270B (da) Fremgangsmåde til fremstilling af benzazolderivater.
DK121706B (da) Fremgangsmåde til fremstilling af monothioetherglycol.
DK114626B (da) Fremgangsmåde til fremstilling af 2-substitueret-4-amino-5-acylamidometylpyrimidin.
FI45952C (fi) Menetelmä formaldehydin valmistamiseksi.
DK117232B (da) Fremgangsmåde til fremstilling af α-aminoacylerede estere af vincaalkaloider.
DK113715B (da) Analogifremgangsmåde til fremstilling af theophyllinderivater.
DK120239B (da) Fremgangsmåde til fremstilling af piperazin-fenylætanolderivater.
DK117071B (da) Fremgangsmåde til fremstilling af 7-[β-hydroxy-γ-(methyl-β-hydroxyethylamino)-propyl]-theophyllinnicotinat.
DK113292B (da) Fremgangsmåde til fremstilling af azabicycloalkaner.
DK117502B (da) Fremgangsmåde til fremstilling af diacetylderivatet af spiramycin II.